[DOI] [PMC free article] [PubMed] [Google Scholar] 90.Bukowska-Strakova K., Wodek J., Pitera E., Kozakowska M., Konturek-Ciela A., Ciela M., Goka M., Nowak W., Wieczorek A., Pawiska-Wsikowska K., et al
This emphasizes the need for an arsenal of medications which target all aspects of the biological changes to defeat this devastating disease, Griffin said
GLP-1s should not be used during early pregnancy and are typically avoided throughout pregnancy and breastfeeding
A 2026 UK review of how HGF activates repair Schwann cells (Ko 2018, Scientific Reports ), the 2021 rat sciatic-nerve study where Dihexa + stem cells improved motor recovery, the VM202 / Engensis HGF gene-therapy Phase 3 in painful diabetic peripheral neuropathy (results posted Jan 2025), chemotherapy-induced neuropathy (CIPN) and the duloxetine question, and the 2026 AthiraLeonaBio pivot taking the oral HGF/MET modulator ATH-1105 into ALS with an honest account of why Dihexa still has zero human neuropathy data Read the full review Neuroscience 27 May 2026 Dihexa for Migraine & Chronic Migraine: The 2026 UK Review Rigorous 2026 UK review of Dihexa for migraine and chronic migraine